Literature DB >> 30508625

Identification of novel immunogenic proteins against Streptococcus parauberis in a zebrafish model by reverse vaccinology.

Young Su Kim1, Nam-Kyung Yoon2, Nadia Karisa3, Sin-Hye Seo2, Jeong-Soo Lee4, Sung-Sik Yoo2, In-Joong Yoon2, Yeu-Chun Kim5, Hongweon Lee3, Jungoh Ahn6.   

Abstract

Streptococcus parauberis is the major infectious agent of streptococcosis in the olive flounder (Paralichthys olivaceus), causing serious economic damage. In this study, we identified potential vaccine candidates against S. parauberis by reverse vaccinology. In total, the 2 out of 21 proteins were identified as vaccine candidates from two available S. parauberis genomes. The membrane-anchored protein SEC10/PgrA and the metal ABC transporter substrate-binding lipoprotein mtsA were potent antigenic proteins based on western blotting with mouse-derived antiserum against whole bacteria of S. parauberis serotypes I and II. In particular, metal ABC transporter substrate-binding lipoprotein (mtsA) showed similar protective immunity to that of whole-cell bacterins against S. parauberis in a zebrafish model. These results suggest that mtsA may be considered as a novel candidate in the development of vaccines against S. parauberis.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  Metal ABC transporter substrate-binding lipoprotein; Reverse vaccinology; Streptococcus parauberis; Subunit vaccine; Zebrafish

Mesh:

Substances:

Year:  2018        PMID: 30508625     DOI: 10.1016/j.micpath.2018.11.053

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  2 in total

Review 1.  Zebrafish as an alternative animal model in human and animal vaccination research.

Authors:  Ricardo Lacava Bailone; Hirla Costa Silva Fukushima; Bianca Helena Ventura Fernandes; Luís Kluwe De Aguiar; Tatiana Corrêa; Helena Janke; Princia Grejo Setti; Roberto De Oliveira Roça; Ricardo Carneiro Borra
Journal:  Lab Anim Res       Date:  2020-05-07

2.  Designing multi-epitope based peptide vaccine targeting spike protein SARS-CoV-2 B1.1.529 (Omicron) variant using computational approaches.

Authors:  Meet Parmar; Ritik Thumar; Jigar Sheth; Dhaval Patel
Journal:  Struct Chem       Date:  2022-09-20       Impact factor: 1.795

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.